Cormark Comments on Vitalhub’s FY2025 Earnings (TSE:VHI)

Vitalhub Corp. (TSE:VHI) – Cormark lowered their FY2025 EPS estimates for Vitalhub in a research report issued on Thursday, October 31st. Cormark analyst G. Fairweather now anticipates that the company will earn $0.18 per share for the year, down from their previous forecast of $0.22. Cormark currently has a “Buy” rating and a $10.50 target price on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share.

Vitalhub Price Performance

TSE:VHI opened at C$10.25 on Friday. The company has a 50 day moving average price of C$8.87 and a 200-day moving average price of C$7.79. Vitalhub has a 1-year low of C$2.87 and a 1-year high of C$10.46. The firm has a market cap of C$521.21 million, a price-to-earnings ratio of 93.18, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.

Vitalhub (TSE:VHI) last announced its quarterly earnings data on Thursday, August 8th. The company reported C($0.01) EPS for the quarter, missing the consensus estimate of C$0.06 by C($0.07). The business had revenue of C$16.24 million for the quarter, compared to analyst estimates of C$15.39 million. Vitalhub had a net margin of 8.14% and a return on equity of 4.73%.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.